O	O	0	12	Constitutive	Constitutive	B-NP	JJ	O	6	NMOD	O
T12	B-Entity	13	15	NF	NF	I-NP	NN	B-protein	6	NMOD	B-protein
T12	I-Entity	15	16	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T12	I-Entity	16	21	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T12	I-Entity	22	23	B	B	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	24	34	activation	activation	I-NP	NN	O	13	NMOD	O
O	O	34	35	,	,	O	,	O	13	P	O
O	O	36	44	enhanced	enhance	B-VP	VBN	O	9	NMOD	O
O	O	45	59	granulopoiesis	granulopoiesis	B-NP	NN	O	13	NMOD	O
O	O	59	60	,	,	O	,	O	13	P	O
O	O	61	64	and	and	O	CC	O	13	NMOD	O
O	O	65	73	neonatal	neonatal	B-NP	JJ	O	13	NMOD	O
O	O	74	83	lethality	lethality	I-NP	NN	O	0	ROOT	O
O	O	84	86	in	in	B-PP	IN	O	13	NMOD	O
T1	B-Protein	87	88	I	I	B-NP	NN	B-protein	18	NMOD	B-protein
T1	I-Protein	89	94	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T1	I-Protein	95	96	B	B	I-NP	NN	I-protein	18	NMOD	I-protein
T1	I-Protein	97	102	alpha	alpha	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	102	103	-	-	B-NP	HYPH	O	21	NMOD	O
O	O	103	112	deficient	deficient	I-NP	JJ	O	21	NMOD	O
O	O	113	117	mice	mouse	I-NP	NNS	O	14	PMOD	O
O	O	117	118	.	.	O	.	O	13	P	O

O	O	120	133	Transcription	Transcription	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	134	141	factors	factor	I-NP	NNS	I-protein	11	SUB	I-protein
O	O	142	151	belonging	belong	B-VP	VBG	O	2	NMOD	O
O	O	152	154	to	to	B-PP	TO	O	3	VMOD	O
O	O	155	158	the	the	B-NP	DT	O	10	NMOD	O
O	O	159	161	NF	NF	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	161	162	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
O	O	162	167	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	168	169	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	170	176	family	family	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	177	180	are	be	B-VP	VBP	O	0	ROOT	O
O	O	181	191	controlled	control	I-VP	VBN	O	11	VC	O
O	O	192	194	by	by	B-PP	IN	O	12	VMOD	O
O	O	195	205	inhibitory	inhibitory	B-NP	JJ	B-protein	18	NMOD	B-protein
O	O	206	207	I	I	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	208	213	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	214	215	B	B	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	216	224	proteins	protein	I-NP	NNS	I-protein	29	NMOD	I-protein
O	O	224	225	,	,	O	,	O	29	P	O
O	O	226	232	mainly	mainly	B-NP	RB	O	29	NMOD	O
T2	B-Protein	233	234	I	I	I-NP	NN	B-protein	24	NMOD	B-protein
T2	I-Protein	235	240	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
T2	I-Protein	241	242	B	B	I-NP	NN	I-protein	24	NMOD	I-protein
T2	I-Protein	243	248	alpha	alpha	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	249	252	and	and	I-NP	CC	O	29	NMOD	O
T3	B-Protein	253	254	I	I	I-NP	NN	B-protein	29	NMOD	B-protein
T3	I-Protein	255	260	kappa	kappa	I-NP	NN	I-protein	29	NMOD	I-protein
T3	I-Protein	261	262	B	B	I-NP	NN	I-protein	29	NMOD	I-protein
T3	I-Protein	263	267	beta	beta	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	267	268	.	.	O	.	O	11	P	O

O	O	269	279	Apparently	Apparently	B-ADJP	RB	O	14	VMOD	O
O	O	280	286	normal	normal	I-ADJP	JJ	O	1	AMOD	O
O	O	287	289	at	at	B-PP	IN	O	1	AMOD	O
O	O	290	295	birth	birth	B-NP	NN	O	3	PMOD	O
O	O	295	296	,	,	O	,	O	9	P	O
T4	B-Protein	297	298	I	I	B-NP	NN	B-protein	8	NMOD	B-protein
T4	I-Protein	299	304	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T4	I-Protein	305	306	B	B	I-NP	NN	I-protein	9	NMOD	I-protein
T4	I-Protein	307	312	alpha	alpha	O	SYM	I-protein	11	P	I-protein
O	O	312	313	-	-	O	HYPH	O	11	P	O
O	O	313	314	/	/	O	SYM	O	14	P	O
O	O	314	315	-	-	O	HYPH	O	13	NMOD	O
O	O	316	320	mice	mouse	B-NP	NNS	O	14	SUB	O
O	O	321	328	exhibit	exhibit	B-VP	VBP	O	0	ROOT	O
O	O	329	335	severe	severe	B-NP	JJ	O	16	NMOD	O
O	O	336	343	runting	runting	I-NP	NN	O	23	NMOD	O
O	O	343	344	,	,	O	,	O	23	P	O
O	O	345	349	skin	skin	B-NP	NN	O	19	NMOD	O
O	O	350	357	defects	defect	I-NP	NNS	O	23	NMOD	O
O	O	357	358	,	,	O	,	O	23	P	O
O	O	359	362	and	and	O	CC	O	23	NMOD	O
O	O	363	372	extensive	extensive	B-NP	JJ	O	23	NMOD	O
O	O	373	387	granulopoiesis	granulopoiesis	I-NP	NN	O	14	OBJ	O
O	O	388	399	postnatally	postnatally	B-ADVP	RB	O	14	VMOD	O
O	O	399	400	,	,	O	,	O	14	P	O
O	O	401	410	typically	typically	B-ADVP	RB	O	27	VMOD	O
O	O	411	416	dying	die	B-VP	VBG	O	14	VMOD	O
O	O	417	419	by	by	B-PP	IN	O	27	VMOD	O
O	O	420	421	8	8	B-NP	CD	O	30	NMOD	O
O	O	422	426	days	day	I-NP	NNS	O	28	PMOD	O
O	O	426	427	.	.	O	.	O	14	P	O

O	O	428	441	Hematopoietic	Hematopoietic	B-NP	JJ	O	2	NMOD	O
O	O	442	449	tissues	tissue	I-NP	NNS	O	6	SUB	O
O	O	450	454	from	from	B-PP	IN	O	2	NMOD	O
O	O	455	460	these	these	B-NP	DT	O	5	NMOD	O
O	O	461	465	mice	mouse	I-NP	NNS	O	3	PMOD	O
O	O	466	473	display	display	B-VP	VBP	O	0	ROOT	O
O	O	474	482	elevated	elevated	B-NP	JJ	O	8	NMOD	O
O	O	483	489	levels	level	I-NP	NNS	O	6	OBJ	O
O	O	490	492	of	of	B-PP	IN	O	8	NMOD	O
O	O	493	497	both	both	O	CC	O	17	NMOD	O
O	O	498	505	nuclear	nuclear	B-NP	JJ	B-protein	12	NMOD	B-protein
O	O	506	508	NF	NF	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	508	509	-	-	B-NP	HYPH	O	15	NMOD	O
O	O	509	514	kappa	kappa	I-NP	NN	O	15	NMOD	O
O	O	515	516	B	B	I-NP	NN	O	17	NMOD	O
O	O	517	520	and	and	O	CC	O	17	NMOD	O
O	O	521	526	mRNAs	mRNA	B-NP	NNS	B-RNA	9	PMOD	B-RNA
O	O	527	529	of	of	B-PP	IN	O	17	NMOD	O
O	O	530	534	some	some	B-NP	DT	O	25	NMOD	O
O	O	534	535	,	,	O	,	O	25	P	O
O	O	536	539	but	but	O	CC	O	25	NMOD	O
O	O	540	543	not	not	B-NP	RB	O	25	NMOD	O
O	O	544	547	all	all	I-NP	DT	O	22	NMOD	O
O	O	547	548	,	,	O	,	O	25	P	O
O	O	549	554	genes	gene	B-NP	NNS	O	18	PMOD	O
O	O	555	562	thought	think	B-VP	VBN	O	25	NMOD	O
O	O	563	565	to	to	I-VP	TO	O	28	VMOD	O
O	O	566	568	be	be	I-VP	VB	O	26	VMOD	O
O	O	569	578	regulated	regulate	I-VP	VBN	O	28	VC	O
O	O	579	581	by	by	B-PP	IN	O	29	VMOD	O
T13	B-Entity	582	584	NF	NF	B-NP	NN	B-protein	34	NMOD	B-protein
T13	I-Entity	584	585	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T13	I-Entity	585	590	kappa	kappa	I-NP	NN	I-protein	34	NMOD	I-protein
T13	I-Entity	591	592	B	B	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	592	593	.	.	O	.	O	6	P	O

O	O	594	596	NF	NF	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	596	597	-	-	I-NP	HYPH	I-protein	4	NMOD	I-protein
O	O	597	602	kappa	kappa	I-NP	NN	I-protein	4	NMOD	I-protein
O	O	603	604	B	B	I-NP	NN	I-protein	5	NMOD	I-protein
O	O	605	614	elevation	elevation	I-NP	NN	O	6	SUB	O
O	O	615	622	results	result	B-VP	VBZ	O	0	ROOT	O
O	O	623	625	in	in	B-PP	IN	O	6	VMOD	O
O	O	626	631	these	these	B-NP	DT	O	10	NMOD	O
O	O	632	642	phenotypic	phenotypic	I-NP	JJ	O	10	NMOD	O
O	O	643	656	abnormalities	abnormality	I-NP	NNS	O	7	PMOD	O
O	O	657	664	because	because	B-SBAR	IN	O	6	VMOD	O
O	O	665	669	mice	mouse	B-NP	NNS	O	28	SUB	O
O	O	670	677	lacking	lack	B-VP	VBG	O	12	NMOD	O
O	O	678	682	both	both	O	CC	O	22	NMOD	O
T5	B-Protein	683	684	I	I	B-NP	NN	B-protein	18	NMOD	B-protein
T5	I-Protein	685	690	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T5	I-Protein	691	692	B	B	I-NP	NN	I-protein	18	NMOD	I-protein
T5	I-Protein	693	698	alpha	alpha	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	699	702	and	and	O	CC	O	22	NMOD	O
O	O	703	706	the	the	B-NP	DT	O	22	NMOD	O
T6	B-Protein	707	710	p50	p50	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	711	718	subunit	subunit	I-NP	NN	I-protein	13	OBJ	I-protein
O	O	719	721	of	of	B-PP	IN	O	22	NMOD	O
T14	B-Entity	722	724	NF	NF	B-NP	NN	B-protein	27	NMOD	B-protein
T14	I-Entity	724	725	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T14	I-Entity	725	730	kappa	kappa	I-NP	NN	I-protein	27	NMOD	I-protein
T14	I-Entity	731	732	B	B	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	733	737	show	show	B-VP	VBP	O	11	SBAR	O
O	O	738	739	a	a	B-NP	DT	O	32	NMOD	O
O	O	740	752	dramatically	dramatically	I-NP	RB	O	31	AMOD	O
O	O	753	760	delayed	delay	I-NP	VBN	O	32	NMOD	O
O	O	761	766	onset	onset	I-NP	NN	O	28	OBJ	O
O	O	767	769	of	of	B-PP	IN	O	32	NMOD	O
O	O	770	783	abnormalities	abnormality	B-NP	NNS	O	33	PMOD	O
O	O	783	784	.	.	O	.	O	6	P	O

O	O	785	787	In	In	B-PP	IN	O	16	VMOD	O
O	O	788	796	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	797	799	to	to	B-PP	TO	O	2	NMOD	O
O	O	800	813	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	5	NMOD	B-cell_type
O	O	814	819	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	819	820	,	,	O	,	O	16	P	O
T7	B-Protein	821	822	I	I	B-NP	NN	B-protein	9	NMOD	B-protein
T7	I-Protein	823	828	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T7	I-Protein	829	830	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
T7	I-Protein	831	836	alpha	alpha	B-VP	SYM	I-protein	15	NMOD	I-protein
O	O	836	837	-	-	B-NP	HYPH	O	15	NMOD	O
O	O	837	838	/	/	I-NP	SYM	O	15	NMOD	O
O	O	838	839	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	840	849	embryonic	embryonic	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	850	861	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	16	SUB	I-cell_type
O	O	862	866	show	show	B-VP	VBP	O	0	ROOT	O
O	O	867	874	minimal	minimal	B-NP	JJ	O	18	NMOD	O
O	O	875	887	constitutive	constitutive	I-NP	JJ	O	35	NMOD	O
O	O	888	890	NF	NF	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	890	891	-	-	B-NP	HYPH	I-protein	22	NMOD	I-protein
O	O	891	896	kappa	kappa	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	897	898	B	B	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	898	899	,	,	O	,	O	35	P	O
O	O	900	902	as	as	B-CONJP	RB	O	35	NMOD	O
O	O	903	907	well	well	I-CONJP	RB	O	24	DEP	O
O	O	908	910	as	as	I-CONJP	IN	O	24	DEP	O
O	O	911	917	normal	normal	B-NP	JJ	O	28	NMOD	O
O	O	918	924	signal	signal	I-NP	NN	O	35	NMOD	O
O	O	924	925	-	-	B-NP	HYPH	O	35	NMOD	O
O	O	925	934	dependent	dependent	I-NP	JJ	O	35	NMOD	O
T15	B-Entity	935	937	NF	NF	I-NP	NN	B-protein	34	NMOD	B-protein
T15	I-Entity	937	938	-	-	I-NP	HYPH	I-protein	34	NMOD	I-protein
T15	I-Entity	938	943	kappa	kappa	I-NP	NN	I-protein	34	NMOD	I-protein
T15	I-Entity	944	945	B	B	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	946	956	activation	activation	I-NP	NN	O	16	OBJ	O
O	O	957	961	that	that	B-NP	WDT	O	35	NMOD	O
O	O	962	964	is	be	B-VP	VBZ	O	36	SBAR	O
O	O	965	976	concomitant	concomitant	B-ADJP	JJ	O	37	PRD	O
O	O	977	981	with	with	B-PP	IN	O	38	AMOD	O
T8	B-Protein	982	983	I	I	B-NP	NN	B-protein	43	NMOD	B-protein
T8	I-Protein	984	989	kappa	kappa	I-NP	NN	I-protein	43	NMOD	I-protein
T8	I-Protein	990	991	B	B	I-NP	NN	I-protein	43	NMOD	I-protein
T8	I-Protein	992	996	beta	beta	I-NP	NN	I-protein	44	NMOD	I-protein
O	O	997	1008	degradation	degradation	I-NP	NN	O	39	PMOD	O
O	O	1008	1009	.	.	O	.	O	16	P	O

O	O	1010	1013	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	1014	1021	results	result	I-NP	NNS	O	3	SUB	O
O	O	1022	1030	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1031	1035	that	that	B-SBAR	IN	O	3	VMOD	O
T9	B-Protein	1036	1037	I	I	B-NP	NN	B-protein	8	NMOD	B-protein
T9	I-Protein	1038	1043	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T9	I-Protein	1044	1045	b	b	I-NP	NN	I-protein	8	NMOD	I-protein
T9	I-Protein	1046	1050	beta	beta	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	1050	1051	,	,	O	,	O	15	P	O
O	O	1052	1055	but	but	O	CC	O	15	NMOD	O
O	O	1056	1059	not	not	O	RB	O	10	DEP	O
T10	B-Protein	1060	1061	I	I	B-NP	NN	B-protein	15	NMOD	B-protein
T10	I-Protein	1062	1067	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T10	I-Protein	1068	1069	B	B	I-NP	NN	I-protein	15	NMOD	I-protein
T10	I-Protein	1070	1075	alpha	alpha	I-NP	NN	I-protein	17	SUB	I-protein
O	O	1075	1076	,	,	O	,	O	15	P	O
O	O	1077	1079	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	1080	1088	required	require	I-VP	VBN	O	17	VC	O
O	O	1089	1092	for	for	B-PP	IN	O	18	VMOD	O
O	O	1093	1096	the	the	B-NP	DT	O	24	NMOD	O
O	O	1097	1103	signal	signal	I-NP	NN	O	24	NMOD	O
O	O	1103	1104	-	-	B-NP	HYPH	O	24	NMOD	O
O	O	1104	1113	dependent	dependent	I-NP	JJ	O	24	NMOD	O
O	O	1114	1124	activation	activation	I-NP	NN	O	19	PMOD	O
O	O	1125	1127	of	of	B-PP	IN	O	24	NMOD	O
T16	B-Entity	1128	1130	NF	NF	B-NP	NN	B-protein	29	NMOD	B-protein
T16	I-Entity	1130	1131	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
T16	I-Entity	1131	1136	kappa	kappa	I-NP	NN	I-protein	29	NMOD	I-protein
T16	I-Entity	1137	1138	B	B	I-NP	NN	I-protein	25	PMOD	I-protein
O	O	1139	1141	in	in	B-PP	IN	O	24	NMOD	O
O	O	1142	1153	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	30	PMOD	B-cell_type
O	O	1153	1154	.	.	O	.	O	3	P	O

O	O	1155	1162	However	However	B-ADVP	RB	O	7	VMOD	O
O	O	1162	1163	,	,	O	,	O	7	P	O
T11	B-Protein	1164	1165	I	I	B-NP	NN	B-protein	6	NMOD	B-protein
T11	I-Protein	1166	1171	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T11	I-Protein	1172	1173	B	B	I-NP	NN	I-protein	6	NMOD	I-protein
T11	I-Protein	1174	1179	alpha	alpha	I-NP	NN	I-protein	7	SUB	I-protein
O	O	1180	1182	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1183	1191	required	require	I-VP	VBN	O	7	VC	O
O	O	1192	1195	for	for	B-PP	IN	O	8	VMOD	O
O	O	1196	1199	the	the	B-NP	DT	O	12	NMOD	O
O	O	1200	1213	postinduction	postinduction	I-NP	NN	O	12	NMOD	O
O	O	1214	1224	repression	repression	I-NP	NN	O	9	PMOD	O
O	O	1225	1227	of	of	B-PP	IN	O	12	NMOD	O
O	O	1228	1230	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	1230	1231	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
O	O	1231	1236	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	1237	1238	B	B	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	1239	1241	in	in	B-PP	IN	O	12	NMOD	O
O	O	1242	1253	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	18	PMOD	B-cell_type
O	O	1253	1254	.	.	O	.	O	7	P	O

O	O	1255	1260	These	These	B-NP	DT	O	2	NMOD	O
O	O	1261	1268	results	result	I-NP	NNS	O	3	SUB	O
O	O	1269	1275	define	define	B-VP	VBP	O	0	ROOT	O
O	O	1276	1284	distinct	distinct	B-NP	JJ	O	5	NMOD	O
O	O	1285	1290	roles	role	I-NP	NNS	O	3	OBJ	O
O	O	1291	1294	for	for	B-PP	IN	O	5	NMOD	O
O	O	1295	1298	the	the	B-NP	DT	O	9	NMOD	O
O	O	1299	1302	two	two	I-NP	CD	O	9	NMOD	O
O	O	1303	1308	forms	form	I-NP	NNS	O	6	PMOD	O
O	O	1309	1311	of	of	B-PP	IN	O	9	NMOD	O
O	O	1312	1313	I	I	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	1314	1319	kappa	kappa	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	1320	1321	B	B	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	1322	1325	and	and	O	CC	O	3	VMOD	O
O	O	1326	1337	demonstrate	demonstrate	B-VP	VBP	O	3	VMOD	O
O	O	1338	1341	the	the	B-NP	DT	O	17	NMOD	O
O	O	1342	1351	necessity	necessity	I-NP	NN	O	15	OBJ	O
O	O	1352	1355	for	for	B-PP	IN	O	17	NMOD	O
O	O	1356	1365	stringent	stringent	B-NP	JJ	O	20	NMOD	O
O	O	1366	1373	control	control	I-NP	NN	O	18	PMOD	O
O	O	1374	1376	of	of	B-PP	IN	O	20	NMOD	O
T17	B-Entity	1377	1379	NF	NF	B-NP	NN	B-protein	25	NMOD	B-protein
T17	I-Entity	1379	1380	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T17	I-Entity	1380	1385	kappa	kappa	I-NP	NN	I-protein	25	NMOD	I-protein
T17	I-Entity	1386	1387	B	B	I-NP	NN	I-protein	21	PMOD	I-protein
O	O	1387	1388	.	.	O	.	O	3	P	O
